Ian Hirsch

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng, Daniel J. Phillips, Thomas White et al. · Nature Medicine · 2021 · 1.2K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies

J. Mark FitzGerald, Eugene R. Bleecker, Andrew Menzies‐Gow et al. · The Lancet Respiratory Medicine · 2017 · 309 citations

Asthma, Rheumatology, Allergy +8

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma

Eugene R. Bleecker, Michael E. Wechsler, J. Mark FitzGerald et al. · European Respiratory Journal · 2018 · 237 citations · Full text